跳至主要内容
临床试验/ACTRN12616001397404
ACTRN12616001397404终止1 期

Intranasal Deposition of fluorescein-dyed Saline delivered by a Nasal Mesh Nebulizer (NMN) at different pulse frequencies in patients that have undergone Functional Endoscopic Sinus Surgery (FESS)

AFT Pharmaceuticals Ltd.0 个研究点目标入组 20 人开始时间: 2016年10月10日最近更新:
适应症

试验速览

阶段
1 期
状态
终止
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Participants (both males and females) that have undergone Functional Endoscopic Sinus Surgery (FESS) more than 3 months before the study
  • 2. Age >= 18 years
  • 3. No history of smoking
  • 4. No history of chronic lung diseases including asthma, cystic fibrosis, tuberculosis, chronic obstructive lung disease
  • 5. Normal lung function with stable and reproducible baseline FEV1 of >80% of predicted value following adjustment for height, age, and gender (according to the Global Lung Initiative equation)

排除标准

  • 1. Significant upper and/or lower respiratory tract infection within the previous 4 weeks
  • 2. History of recurrent lung infections
  • 3. History of chronic lung diseases
  • 4. History of severe or multiple allergies, including hay-fever and perennial rhinitis
  • 5. Participants using nasal decongestant within 14 days of entering the study
  • 6. Participants with documented or suspected, clinically significant alcohol or drug abuse
  • 7. Known history of adverse reaction to fluorescein

研究者

相似试验